Abstract. Colchicine and other microtubule-active agents have been found to block the release, stimulated by either thyroid-stimulating hormone or by dibutyryl cyclic adenosine 3':5'-monophosphate, of 1311 from previously 13lJ-labeled mouse thyroid glands in vitro. The time and concentration characteristics of these inhibitors are consistent with their actions on microtubules in other systems.
Uptake and distribution of [3H] colchicine: We studied the uptake of [3H]colchicine (New England Nuclear, specific activity 2.5 Ci/mmol) by bovine thyroid glands. Slices weighing 50-60 mg were incubated at 370C in 3 ml of Earle's solution containing bovine serum albumin (2 mg/ml) and 0.2 gCi/ml of ['H colchicine at the concentrations indicated in the text. After 0.5-6 hr, the slices were lightly blotted, rinsed three times for 3 min each in Earle's solution and dissolved in scintillation vials in 0.5 ml of Soluene (Packard). 15 ml of Bray's solution was then added and, after the decay of chemoluminescence, radioactivity was measured. Quenching was corrected for by the use of an internal standard.
To evaluate the state of intracellular ['H colchicine, we incubated 500 mg of bovine thyroid gland slices at 370C in Earle's solution containing [3H]colchicine (1 MCi/ml, 2 X 10-l M) for 2 hr, and homogenized them in 3 volumes of 250 mM sucrose-10 mM MgC12-10 mM phosphate buffer (pH 7.0)-0.1 mM GTP. Homogenization and all subsequent operations took place at 20C. The homogenates were centrifuged for 1 hr at 100,000 X g and aliquots of the original homogenate and supernatant solution were taken for determination of radioactivity as above. Colchicine binding to macromolecules in the 100,000 X g supernatant solution was tested by gel filtration on a 1.5 X 15.0 cm Sephadex G-100 column eluted with 10 mM phosphate buffer (pH 7.0)-10 mM MgC12-0.1 mM GTP.
Thirty 1.5-ml fractions were collected and 0.2 ml of each was added to 10 ml of Aquasol (New England Nuclear) for radioactivity determination. Protein was estimated as A2so
read against an eluent-buffer blank.
Linear 5-28% sucrose gradients, 4.8 ml per tube, were prepared containing 100 mM KC1, 10 mM Na phosphate buffer (pH 7.0), and 10 mM MgC12. A 0.2-ml aliquot from the bound colchicine peak was layered over the buffered sucrose gradient and centrifuged at 20C for 3.5 hr at 65,000 rpm in the Spinco Model L2-65B centrifuge. Crystalline bovine serum albumin and crystalline rabbit muscle glyceraldehyde-3-phosphate dehydrogenase (EC 1.2.1.12) were added as markers. Protein was determined by fluorescence read at 340 nm and radioactivity by counting in the Aquasol system.
Thin-layer chromatography on silica-gel chromatogram sheet was carried out using methanol or n-butanol saturated with ammonia and water according to the method of Wilson and Friedkin.9 Results. Inhibition of thyroid secretion in vitro by colchicine: Preincubation with colchicine was required to give inhibition of the TSH effect. Fig. 1 , top, shows a dose-response curve of thyroid "3'I release during a 4-hr incubation after a 2-hr preincubation. Note the steep decrease of the TSH effect between 10-7 and 10-6 M and the lack of effect of colchicine on basal release at concentrations up to 10-' M. In other experiments (not shown) colchicine, at concentrations above 10-3 M, released iodoprotein; this has been shown to indicate thyroid damage. 15 Fig . 2 shows the per cent inhibition of the TSH response as a function of colchicine concentration and different preincubation times. Increasing the duration of preincubation increases the degree of maximal inhibition and decreases the concentration required for 50% inhibition; the latter are as low as 1.5 X 10-7 M after a 4-hr preincubation.
Colchicine also inhibited the release of thyroidal 1311 in response to Bu2cAM\fP (Table 1) . As noted previously'5, 1 X 10-4 M Bu2cAMP stimulated approximately the same release of 131I from the mouse thyroid as did 2 mU/ml TSH. This stimulated release was inhibited to about the same extent at two different concentrations of colchicine.
To help localize the site of inhibition, we fixed thyroids after preincubation and incubation with or without colchicine and TSH, and examined them histo- logically. Whereas colchicine alone had no effect on glandular morphology, it virtually abolished TSH-induced colloid droplet formation (Fig. 3 ).
Since the action of TSH on thyroid secretion is believed to be mediated by cyclic AMP, possible sites of inhibition include inhibition of adenyl cyclase and stimulation of cyclic 3':5'-nucleotide phosphodiesterase. However, no effect of colchicine on basal, TSH-, or fluoride-stimulated adenyl cyclase activity of purified bovine thyroid membrane could be detected (Table 2) . Moreover, no effect on phosphodiesterase was seen (Table 2 ). On the assumption that colchicine acts on microtubules, other agents known to affect this organelle were tested. Vinblastine was found to inhibit TSHinduced secretion (Fig. 1, bottom) . Of interest is the flattened dose-response curve characteristic of the actions of this agent on other systems.18 Table 3 gives the 50% inhibitory concentration for TSH-induced "3'I release as well as the relative concentration at which mitosis is blocked for a number of spindle inhibitors. Of the well-studied agents, only griseofulvin failed to inhibit thyroid secretion. PROC. N. A. S.
Inhibition of in vitro TSH-stimulated thyroidal 1311 release by coichicine with different lengths of preincubation. Release was measured over a 6-hr period without preincubation, over 5 hr after a 1-hr preincubation and over 4 hr after 2-and 4-hr preincubations. In each case the difference between TSH and control release in the absence of coichicine is taken as 100%o. Each point is the mean of two separate experiments determined in triplicate.
Demonstration of a thyroidal coichicine-bindin protein: The action of coichicine on microtubule-associated functions has recently been related to coichicine binding of a protein thought to be a microtubule subunit.7-12 The uptake and binding of [3HIcoichicine by bovine thyroid gland slices was therefore studied. Fig. 4 shows the uptake of coichicine by thyroid slices at three different concentrations. Both the rate of equilibration and the final amount taken up are dependent on the colchicine concentration in the medium. It is probable that the time and concentration dependence for inhibition of TSR-induced 131J release (Fig. 2) can be explained as due to the need to attain effective tissue concentrations. Homogenization in the sucrose-GTP buffer and centrifugation showed that over 95 %0 of the radioactivity was in the 100,000 X g supernatant fraction.
When an aliquot of this material was passed through a Sephadex G-100 column a bound fraction was separated from free colchicine. A typical elution profile is shown in Fig. 5A . The bound-colchicine peak emerged immediately behind the protein peak, which elutes in the void volume and is primarily thyroglobulin. Colchicine-binding activity was essentially abolished by pronase digestion. Thin-layer chromatography of a concentrated solution of the bound fraction gave a single spot with RJ similar to that of the original [3H]colchicine and carrier. 6.2+i0.6 3.9+i0.6
All values are mean + SE for 3-6 thyroids preincubated for 2 hr in Earle's medium to which colchicine had been added and then incubated 4 hr with TSH or Bu~cA~MP also present as specified. Release during the 4-hr incubation is expressed as a percentage of the original thyroid content. When an aliquot from the bound-colchicine peak w-as subjected to sucrose gradient centrifugation the labeled material sedimented wsith a sedimentation coefficient of 6 S between the serum albumin and glyceraldehyde-phosphate-dehydrogenase markers (Fig. 5B) the microtubule this implies a previously unrecognized dependence of thyroid secretion on this organelle. It is thus worthwhile to examine the evidence that the effect is so mediated. Colchicine and related agents were found to be inhibitory at the same low concentrations in which they interfere with microtubule-mediated functions in other systems.'-6 Thyroid secretion also shares with these other systems the time and concentration dependence for inhibitory activity (Fig. 2)3,19 and the more gradual dose-response curve characteristic of vinblastinel8 (Fig. 1) . Furthermore, the relative potency of podophyllotoxin and colcemide are consistent with their potencies on the dissolution of spindle fibers9l18 (Table 3) . The chemical requirements for inhibition of thyroid hormone secretion are thus seen to be quite analogous to those that characterize other microtubular systems.
Another property of microtubule-containing systems is the presence of 6S
colchicine-binding protein in the soluble fraction of homogenates.7-'2 The thyroid gland appears to contain a similar protein (Fig. 5) . Since the thyroid gland has also been shown to contain microtubules, both in the occasional ciliated cells20-22 as well as in the normal epithelial cell23-25 it appears likely that the site The current concept of the mechanism of secretion of the thyroid hormone is that TSH stimulates adenyl cyclase present in the basal membrane and thereby increases cellular levels of cyclic AMP, which in turn stimulates endocytosis at the apical membrane. The resorbed colloid droplets fuse with lysosomes, the thyroglobulin is digested there, and hormone is eventually released to the circulation. 26 The site of action of colchicine is clearly beyond the stage of the accumulation or maintenance of cyclic AMP since colchicine also inhibited the Bu2cAMP stimulated 131I release and since neither adenyl cyclase nor the 3': 5'-cyclic nucleotide phosphodiesterase activities are altered substantially by high concentrations of colchicine (Table 2) . Our results therefore suggest that microtubules may play a role in thyroid secretion through an effect on endocytosis.
Abbreviations: TSH, thyroid-stimulating hormone; Bu2cAMP, N'-2-O-dibutyryl 3:5'-cyclic AMP.
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